KR20010013618A - 치료학적 활성 조성물 - Google Patents

치료학적 활성 조성물 Download PDF

Info

Publication number
KR20010013618A
KR20010013618A KR19997011628A KR19997011628A KR20010013618A KR 20010013618 A KR20010013618 A KR 20010013618A KR 19997011628 A KR19997011628 A KR 19997011628A KR 19997011628 A KR19997011628 A KR 19997011628A KR 20010013618 A KR20010013618 A KR 20010013618A
Authority
KR
South Korea
Prior art keywords
component
composition
abdominal
pharmaceutically acceptable
mammal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR19997011628A
Other languages
English (en)
French (fr)
Korean (ko)
Inventor
피오나 케이트 가디너
Original Assignee
데일 마틴
레키트 앤드 콜맨 프로덕츠 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 데일 마틴, 레키트 앤드 콜맨 프로덕츠 리미티드 filed Critical 데일 마틴
Publication of KR20010013618A publication Critical patent/KR20010013618A/ko
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1635—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR19997011628A 1997-06-10 1998-06-08 치료학적 활성 조성물 Withdrawn KR20010013618A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9711962.2 1997-06-10
GBGB9711962.2A GB9711962D0 (en) 1997-06-10 1997-06-10 Therapeutically active compositions
PCT/GB1998/001673 WO1998056356A1 (en) 1997-06-10 1998-06-08 Therapeutically active compositions

Publications (1)

Publication Number Publication Date
KR20010013618A true KR20010013618A (ko) 2001-02-26

Family

ID=10813845

Family Applications (1)

Application Number Title Priority Date Filing Date
KR19997011628A Withdrawn KR20010013618A (ko) 1997-06-10 1998-06-08 치료학적 활성 조성물

Country Status (17)

Country Link
US (1) US6201014B1 (https=)
EP (1) EP0988028B1 (https=)
JP (1) JP2002513418A (https=)
KR (1) KR20010013618A (https=)
CN (1) CN1198594C (https=)
AR (1) AR012960A1 (https=)
AT (1) ATE262892T1 (https=)
AU (1) AU737606B2 (https=)
BR (1) BR9809994A (https=)
CA (1) CA2291796C (https=)
DE (1) DE69822822T2 (https=)
GB (3) GB9711962D0 (https=)
HU (1) HUP0004245A2 (https=)
ID (1) ID22878A (https=)
PL (1) PL337337A1 (https=)
WO (1) WO1998056356A1 (https=)
ZA (1) ZA984920B (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003086441A1 (en) * 2002-04-12 2003-10-23 Pangenomics Co., Ltd Crude drug composition for preventing and treating gastrointestinal dyskinetic diseases

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6790207B2 (en) * 1998-06-04 2004-09-14 Curon Medical, Inc. Systems and methods for applying a selected treatment agent into contact with tissue to treat disorders of the gastrointestinal tract
US20110071468A1 (en) * 1998-06-04 2011-03-24 Mederi Therapeutics, Inc. Systems and methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction
US6802841B2 (en) * 1998-06-04 2004-10-12 Curon Medical, Inc. Systems and methods for applying a selected treatment agent into contact with tissue to treat sphincter dysfunction
GB9812426D0 (en) * 1998-06-10 1998-08-05 Reckitt & Colmann Prod Ltd Improvements in or relating to organic compositions
GB9925127D0 (en) * 1999-10-22 1999-12-22 Pharmacia & Upjohn Spa Oral formulations for anti-tumor compounds
AU3582101A (en) * 2000-03-01 2001-09-12 Euro-Celtique S.A. The treatment of functional gastrointestinal disorders
US6759064B2 (en) 2001-02-22 2004-07-06 Purdue Research Foundation Compositions based on vanilloid-catechin synergies for prevention and treatment of cancer
US7192612B2 (en) * 2001-02-22 2007-03-20 Purdue Research Foundation Compositions and methods based on synergies between capsicum extracts and tea catechins for prevention and treatment of cancer
US6428822B1 (en) 2001-04-03 2002-08-06 Chengzhi Life Science Company, Ltd. Extracts of mixed arctium lappa L., carrot and whole radish for treating hypertension, constipation and detoxification
US6682759B2 (en) * 2002-02-01 2004-01-27 Depomed, Inc. Manufacture of oral dosage forms delivering both immediate-release and sustained-release drugs
MXPA05006670A (es) 2002-12-18 2005-10-19 Algorx Pharmaceuticals Inc Administracion de capsaicinoides.
US20040161481A1 (en) * 2002-12-18 2004-08-19 Algorx Administration of capsaicinoids
US20050085652A1 (en) * 2003-04-08 2005-04-21 Algorx Pharmaceuticals, Inc. Preparation and purification of synthetic capsaicin
US20100159000A1 (en) * 2003-11-10 2010-06-24 Lundeen Sr James E Medicine for treating gastrointestinal disorder including fecal incontinence
AT413646B (de) * 2004-04-02 2006-04-15 Hammer Johann Dr Verwendung von capsaicin und/oder capsaicinoiden
US20050277657A1 (en) * 2004-06-15 2005-12-15 Dusan Ninkov Method of protection of biologically active essential oils and pharmaceutical composition for weight control and enhance fat burning in adults, adolescents and children
AU2005309586A1 (en) * 2004-11-24 2006-06-01 Algorx Pharmaceuticals, Inc. Capsaicinoid gel formulation and uses thereof
JP5775246B2 (ja) 2004-12-28 2015-09-09 メステックス アクチェンゲゼルシャフトＭｅｓｔｅｘ Ａｇ 関節痛を治療する薬剤を生成するためのレシニフェラトキシン（ｒｔｘ）の使用方法および前記薬剤を適用する方法
WO2008052183A2 (en) 2006-10-27 2008-05-02 Bmb Patent Holding Corporation Therapeutic compositions and methods of treatment with capsianoside-type compounds
AU2008292907A1 (en) * 2007-08-29 2009-03-05 Sorbent Therapeutics, Inc. Absorbent polymeric compositions with varying counterion content and their methods of preparation and use
KR20090047637A (ko) * 2007-11-08 2009-05-13 재단법인서울대학교산학협력재단 커큐민 또는 이의 약학적으로 허용가능한 염을유효성분으로 함유하는 통증 예방 및 치료용 조성물
HUP0700755A2 (en) * 2007-11-26 2009-08-28 Pannonpharma Gyogyszergyar Pharmaceutical compositions containing capsaicionoid and non-steroidal anti-inflammatory drug
US8697155B2 (en) * 2008-07-22 2014-04-15 Mayo Foundation For Medical Education And Research Treatment of obesity and related disorders
US20110200669A1 (en) * 2010-02-15 2011-08-18 Winston Laboratories, Inc. Method and compositions of civamide to treat disease of the intestines
KR101378973B1 (ko) * 2012-04-13 2014-03-28 한미약품 주식회사 구형에 가까운 형태의 다중 투여 단위 정제를 포함하는 경질 캡슐 복합 제형 및 이의 제조방법
CN103027901B (zh) * 2012-12-11 2014-11-12 广东药学院 一种载辣椒素壳聚糖微球肠溶片及其制备方法
US10092528B2 (en) 2013-03-13 2018-10-09 Altria Client Services Llc Application of encapsulated capsaicin and analogues thereof for controlling calorie intake
US9289418B2 (en) 2013-03-15 2016-03-22 Cedars-Sinai Medical Center Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
JP2016516717A (ja) 2013-03-15 2016-06-09 シーダーズ−サイナイ メディカル センター メタン細菌に起因または関連する疾患および状態を診断、選択、および処置する方法
JP2017509596A (ja) 2014-01-30 2017-04-06 オムニアクティブ ヘルス テクノロジーズ リミテッド 辛味がある油性芳香性物質の組成物およびその調製方法
KR102425303B1 (ko) 2014-08-13 2022-07-25 세다르스-신나이 메디칼 센터 항-메탄생성 조성물 및 그것의 용도
WO2016161085A1 (en) * 2015-04-01 2016-10-06 Cedars-Sinai Medical Center Anti-methanogenic lovastatin analogs or derivatives and uses thereof
WO2021011002A1 (en) * 2019-07-18 2021-01-21 Dignify Therapeutics, Llc Compositions and methods for inducing defecation
FI4135652T3 (fi) * 2020-04-15 2025-01-21 Gruenenthal Gmbh Resiniferatoksiinikoostumuksia
AU2022207425A1 (en) * 2021-01-15 2023-07-06 Dignify Therapeutics, Llc Compositions and methods for inducing defecation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2207705A1 (en) * 1972-11-24 1974-06-21 Marconnet Rene Deodorisation of body odours - by liberation of odoriferous substances in the intestines
EP0015334B1 (en) * 1977-08-04 1982-05-19 J.B. Tillott Limited Carminative preparations containing peppermint oil or its active components
US4681897A (en) * 1984-01-16 1987-07-21 The Procter & Gamble Company Pharmaceutical products providing enhanced analgesia
HU206082B (en) * 1988-12-23 1992-08-28 Sandoz Ag Process for producing capsaicin derivatives and pharmaceutical compositions comprising such compounds
US5403868A (en) 1988-12-23 1995-04-04 Sandoz Ltd. Capsaicin derivatives
US5063060A (en) 1989-12-19 1991-11-05 Cisco Limited Partnership Compositions and method for treating painful, inflammatory or allergic disorders
DE4137540A1 (de) * 1991-11-14 1993-05-19 Steigerwald Arzneimittelwerk Verwendung von praeparaten der curcuma-pflanzen
US5431914A (en) 1992-04-17 1995-07-11 Adekunle; Michael Method of treating an internal condition by external application of capsaicin without the need for systemic absorption
DE4392300T1 (de) * 1992-05-21 1995-12-07 Jeff J Staggs Therapeutische Gebräuche von beißenden Pflanzen und Ihre Verwandten Zusammensetzungen
US5762963A (en) * 1995-06-07 1998-06-09 Emory University Method and compositions for controlling oral and pharyngeal pain using capsaicinoids
EP0839037B1 (en) * 1995-07-14 2002-11-13 Sabinsa Corporation Bioprotectant composition, method of use and extraction process of curcuminoids

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003086441A1 (en) * 2002-04-12 2003-10-23 Pangenomics Co., Ltd Crude drug composition for preventing and treating gastrointestinal dyskinetic diseases

Also Published As

Publication number Publication date
US6201014B1 (en) 2001-03-13
ZA984920B (en) 1999-07-01
EP0988028B1 (en) 2004-03-31
PL337337A1 (en) 2000-08-14
GB2332147B (en) 1999-10-27
ATE262892T1 (de) 2004-04-15
ID22878A (id) 1999-12-16
BR9809994A (pt) 2000-08-01
GB2332147A (en) 1999-06-16
EP0988028A1 (en) 2000-03-29
DE69822822D1 (de) 2004-05-06
AU7782998A (en) 1998-12-30
CN1198594C (zh) 2005-04-27
GB9711962D0 (en) 1997-08-06
CA2291796C (en) 2008-03-25
CN1259863A (zh) 2000-07-12
WO1998056356A1 (en) 1998-12-17
GB9827192D0 (en) 1999-02-03
AU737606B2 (en) 2001-08-23
CA2291796A1 (en) 1998-12-17
GB9811819D0 (en) 1998-07-29
HUP0004245A2 (hu) 2001-08-28
AR012960A1 (es) 2000-11-22
DE69822822T2 (de) 2005-01-13
JP2002513418A (ja) 2002-05-08

Similar Documents

Publication Publication Date Title
CA2291796C (en) Therapeutically active compositions
CA2182004C (en) Film coated tablet of paracetamol and domperidone
KR20010040484A (ko) 셀레코시브 조성물
MX2008013871A (es) Metodo para el tratamiento de sindrome del intestino irritable predominante-diarrea.
EP1085860A1 (en) Formulations for the treatment of gastro-oesophageal reflux
CN106074445B (zh) 包衣药物球状体及其制备消除或减少病症的药物的用途
KR101050015B1 (ko) 위체류약물전달시스템을 이용한 애엽 추출물의 약학조성물및 이를 이용한 서방성 경구용 제제
CA3055777A1 (en) Deuterated domperidone compositions, methods, and preparation
JPH09504280A (ja) センナ剤形
PL200132B1 (pl) Zastosowanie 3-(5-metoksy-1H-indol-3-ilometyleno)-N-pentylokarbazyimidoamidu
US20230018600A1 (en) Controlled release formulations comprising drotaverine or salt thereof
JP4152641B2 (ja) チアゾリジン誘導体の副作用軽減剤
US20060122275A1 (en) Agentfor reducing side effects of diclofenac
US9155704B1 (en) More palatable, bioequivalent pharmaceutical composition of carprofen
MXPA99011247A (en) Therapeutically active compositions
EP4035672A1 (en) Drug combination for preventing or treating irritable bowel syndrome
CZ443399A3 (cs) Terapauticky aktivní kompozice
RU2833481C2 (ru) Распадающаяся в ротовой полости фармацевтическая композиция, содержащая нефопам, и способ ее получения
EA003584B1 (ru) Способ стимуляции отказа от курения или его снижения или предупреждения возобновления курения и применение пароксетина или его фармацевтически приемлемых солей или сольватов для получения лекарственного средства
RU2787993C2 (ru) Комбинированные терапии для лечения гепатоцеллюлярной карциномы
RU2121347C1 (ru) Лекарственный препарат
JPH02311422A (ja) コリン・アセチル転移酵素活性賦活剤
CN106890183A (zh) 一种高生物利用度的达比加群酯药物组合物
JPWO2005058878A1 (ja) 月経困難症の予防および／または治療剤
Shivling Design and Evaluation of Fast Dissolving Tablets of Atenolol

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 19991209

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
PC1203 Withdrawal of no request for examination
WITN Application deemed withdrawn, e.g. because no request for examination was filed or no examination fee was paid